Equities Analysts Offer Predictions for McKesson Q1 Earnings

McKesson Co. (NYSE:MCK) – Analysts at Leerink Partnrs issued their Q1 2026 earnings per share estimates for shares of McKesson in a report issued on Wednesday, April 2nd. Leerink Partnrs analyst M. Cherny expects that the company will post earnings of $8.34 per share for the quarter. The consensus estimate for McKesson’s current full-year earnings is $32.77 per share. Leerink Partnrs also issued estimates for McKesson’s Q2 2026 earnings at $8.57 EPS, Q3 2026 earnings at $9.46 EPS, Q4 2026 earnings at $10.38 EPS and FY2026 earnings at $36.75 EPS.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%.

A number of other research analysts have also recently weighed in on the stock. Bank of America cut their price objective on shares of McKesson from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Wells Fargo & Company upped their price target on shares of McKesson from $641.00 to $691.00 and gave the company an “equal weight” rating in a report on Friday, March 14th. StockNews.com lowered McKesson from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. Morgan Stanley increased their price target on McKesson from $642.00 to $745.00 and gave the stock an “overweight” rating in a report on Wednesday. Finally, Mizuho started coverage on McKesson in a report on Wednesday, December 4th. They set a “neutral” rating and a $630.00 price objective for the company. Two analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, McKesson currently has a consensus rating of “Moderate Buy” and an average price target of $656.71.

McKesson Trading Up 3.0 %

Shares of NYSE:MCK opened at $694.12 on Thursday. The company has a market cap of $86.99 billion, a price-to-earnings ratio of 31.78, a PEG ratio of 1.29 and a beta of 0.52. McKesson has a 12 month low of $464.42 and a 12 month high of $702.27. The company has a 50-day moving average price of $629.16 and a 200 day moving average price of $582.85.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Monday, March 3rd were given a $0.71 dividend. This represents a $2.84 annualized dividend and a dividend yield of 0.41%. The ex-dividend date of this dividend was Monday, March 3rd. McKesson’s payout ratio is currently 13.00%.

Insider Buying and Selling

In other news, EVP Leann B. Smith sold 188 shares of the firm’s stock in a transaction dated Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total value of $114,602.92. Following the completion of the transaction, the executive vice president now directly owns 1,051 shares in the company, valued at $640,679.09. This trade represents a 15.17 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Brian S. Tyler sold 8,961 shares of the company’s stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the completion of the sale, the chief executive officer now owns 60,664 shares in the company, valued at approximately $36,276,465.36. This represents a 12.87 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 18,110 shares of company stock worth $10,855,706 in the last three months. Corporate insiders own 0.11% of the company’s stock.

Institutional Trading of McKesson

Institutional investors and hedge funds have recently bought and sold shares of the business. Public Sector Pension Investment Board grew its position in McKesson by 18.8% during the 3rd quarter. Public Sector Pension Investment Board now owns 5,678 shares of the company’s stock worth $2,807,000 after purchasing an additional 900 shares during the period. Erste Asset Management GmbH purchased a new position in McKesson during the third quarter valued at approximately $764,000. Benjamin Edwards Inc. lifted its holdings in McKesson by 58.9% in the third quarter. Benjamin Edwards Inc. now owns 5,917 shares of the company’s stock valued at $2,930,000 after acquiring an additional 2,194 shares during the period. Hilltop Holdings Inc. grew its stake in shares of McKesson by 109.0% during the 3rd quarter. Hilltop Holdings Inc. now owns 1,467 shares of the company’s stock worth $725,000 after purchasing an additional 765 shares during the period. Finally, Janus Henderson Group PLC increased its holdings in shares of McKesson by 126.8% during the 3rd quarter. Janus Henderson Group PLC now owns 574,440 shares of the company’s stock valued at $283,903,000 after purchasing an additional 321,119 shares in the last quarter. 85.07% of the stock is currently owned by institutional investors and hedge funds.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.